Yulia Volchek

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced

Avichai Shimoni, Noga Shem‐Tov, Angela Chetrit et al. · Leukemia · 2012 · 62 citations

Cell Therapy, Transplantation, Marrow Transplantation +14

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or <scp>P</scp>hiladelphia chromosome–positive acute lymphoblastic leukemia

Avichai Shimoni, Yulia Volchek, Maya Koren‐Michowitz et al. · Cancer · 2014 · 60 citations · Full text

The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma

Abraham Avigdor, Tsvi Sirotkin, Meirav Kedmi et al. · Annals of Hematology · 2014 · 58 citations

Lymphoid Neoplasia, Interim Fdg-pet/ct, Medicine +7

Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity

Avichai Shimoni, Noga Shem‐Tov, Yulia Volchek et al. · Bone Marrow Transplantation · 2012 · 52 citations

Pharmaceutical Science, Medicine, Bu-based Regimens +5

Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC

Maya Koren‐Michowitz, Yulia Volchek, Elizabeth Naparstek et al. · Hematological Oncology · 2012 · 39 citations